Blog

Susan had watched the heart-wrenching journey of her mother’s Alzheimer’s disease. After finding out that she was genetically predisposed, she adopted lifestyle changes with the help of Dr. David Merrill at PNI’s Pacific Brain Health Center.

U.S. News & World Report highlights quality, specialty care Providence Southern California hospitals and affiliates received more than 100 honors from the U.S. News & World Report, which released its Best Hospital ratings in July 2021. The report, which reviews hospital performance in adult, pediatric,...

BY NANCY SOKOLER STEINER / PHOTOGRAPHED BY PHILLIP GRAYBILL Thankful for medical research that has benefited them, the McLoughlin family donates to help others. Barbara and John McLoughlin have turned to Providence Saint John’s Health Center for their medical needs for close to six decades....

Dr. Sarah McEwen has wanted to be a brain scientist since she was a kid. At an early age, she realized that exercise made her feel good. Later, she learned why: Physical activity can change the brain because of something called neuroplasticity. The brain isn’t static. It changes and adapts. And that’s one of the most amazing things about an already amazing organ.

PNI’s Year-in-Review 2020 was, despite the pandemic, a strong year for clinical care delivered by PNI providers with multiple milestones being achieved.  We’ve entered 2021 with a deep commitment to treating our patients at our ten centers of excellence, doing groundbreaking research, providing innovative clinical...

One in ten Americans who are 65 and older suffer from Alzheimer’s dementia. It’s the 6th leading cause of death in the country, and it is a scourge worldwide. But little is known about what causes Alzheimer’s, and cures have been elusive. Dr. Verna Porter specializes in treating people with Alzheimer’s, and she remains optimistic.

Although our medical community continues to strain under the burden of COVID-19, there has been hope, determination and progress. Neurological diseases do not stop and neither have we at Pacific Neuroscience Institute.

New Studies Blue Earth Diagnostics FLC-219: (PDF): An Open-label, Single-arm, Single-dose, Prospective, Multicenter Phase 2b Study to Establish Image Interpretation Criteria for 18F-Fluciclovine Positron Emission Tomography (PET) in Detecting Recurrent Brain Metastases After Radiation Therapy (PURSUE) (NCT04410367) Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...

Actively Recruiting Studies Brain Cancer (Primary) – Glioma Aadi Bioscience (PDF): A Phase 2, Open-label Study of ABI-009 (nab-Rapamycin) in Bevacizumab-naïve Patients with Recurrent High-grade Glioma and in Patients with Newly Diagnosed Glioblastoma (NCT03463265) Orbus Therapeutics (PDF): A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine...